http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 17 Jul 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/CAMP4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26784323.html <p>CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=02MachkzIX7ZL3La99rBImoJ5374GO-U7HHgBba6S9poWOK39WYLFGkIGsEWl9PcrpCKy9dqfpZnikVSa9EmTKLdOUCO_haUPszVxFPkoxAEQ4hF7grxlHg7gtWID1KD7SpTYN1bK2aEXkvF-YhLVwiyVv3F-zZC3RqM-4INL_G6KSUbwgCXVkQ0tGD9st3VmAhigrfzaD6hp6sTYjGWSgTkVPW_X7nY7Hd0fLIxixfkRaw3Kp2OEr4o_aR05MsJuSJnXYe0_z3nrbOAsxdLyPAeFOdz764Vow38E7gdCfkVSTo0NnqUU6Z8ouX3jp11moVVtmFl3kRbn1dtqsVJLnoAVTUfIQoeBe7v_ZUeZjCAjLmdrOWkQQhDcv3vjUeL84pGtvpXlEcyIFDjo5CX1LS4Fg5sz5KH-bxzGOpLBJyL_CFtL1K5jxsztxnDduAlrGrgLrMgrzhuakXLVt_a032fhBGgk5yd5t8MYEA2K2islODBEhPN-ttTxe6q8SgO48KV645RbHCZLUmB-TOrPDWCPCprIJv9GUSEyBwb-D-X0LePCZ_5JfIw83VE0Bv5giufbdK-hl9TPGZGEIqatdvs9xbhCWvXGVKgFTRv8e8HAT_EIyW_N-lUxgt-vFBqp3rAYfxP-SYrZWB8VUsTsVNKQlOCKVG48LsMvrIzDuGnpzxdu5VF1l9xSivhQwVXJejSzxj6-OcRyOYIDW8X1kQyU_5hoKRxF11HauDr-GZtneZXIlt8N7wpgfSBH8_x9kubgNbFZ8VkA8qCF3Vf1LdWuvuCLupapVPgJmtR_9nnJfEM-MxUoFjV7X9DQGPZJDRv7tq4vp6aOStUQFzcVhPeu3fX__-Ayudje3SmLjEFFHmLSnegzKujyYezuSh2yes6yqxhxM1HnjnNz0TApg==" rel="nofollow" target="_blank">CAMP4 Therapeutics Corporation</a> (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on July 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option to purchase 8,000 shares of the Company’s common stock to a newly hired employee of the Company as an inducement material to such http://www.streetinsider.com/Press+Releases/CAMP4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26784323.html Fri, 17 Jul 2026 16:05:00 -0400 CAMP http://www.streetinsider.com/Globe+Newswire/CAMP4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26784323.html <p>CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=02MachkzIX7ZL3La99rBImoJ5374GO-U7HHgBba6S9poWOK39WYLFGkIGsEWl9PcrpCKy9dqfpZnikVSa9EmTKLdOUCO_haUPszVxFPkoxAEQ4hF7grxlHg7gtWID1KD7SpTYN1bK2aEXkvF-YhLVwiyVv3F-zZC3RqM-4INL_G6KSUbwgCXVkQ0tGD9st3VmAhigrfzaD6hp6sTYjGWSgTkVPW_X7nY7Hd0fLIxixfkRaw3Kp2OEr4o_aR05MsJuSJnXYe0_z3nrbOAsxdLyPAeFOdz764Vow38E7gdCfkVSTo0NnqUU6Z8ouX3jp11moVVtmFl3kRbn1dtqsVJLnoAVTUfIQoeBe7v_ZUeZjCAjLmdrOWkQQhDcv3vjUeL84pGtvpXlEcyIFDjo5CX1LS4Fg5sz5KH-bxzGOpLBJyL_CFtL1K5jxsztxnDduAlrGrgLrMgrzhuakXLVt_a032fhBGgk5yd5t8MYEA2K2islODBEhPN-ttTxe6q8SgO48KV645RbHCZLUmB-TOrPDWCPCprIJv9GUSEyBwb-D-X0LePCZ_5JfIw83VE0Bv5giufbdK-hl9TPGZGEIqatdvs9xbhCWvXGVKgFTRv8e8HAT_EIyW_N-lUxgt-vFBqp3rAYfxP-SYrZWB8VUsTsVNKQlOCKVG48LsMvrIzDuGnpzxdu5VF1l9xSivhQwVXJejSzxj6-OcRyOYIDW8X1kQyU_5hoKRxF11HauDr-GZtneZXIlt8N7wpgfSBH8_x9kubgNbFZ8VkA8qCF3Vf1LdWuvuCLupapVPgJmtR_9nnJfEM-MxUoFjV7X9DQGPZJDRv7tq4vp6aOStUQFzcVhPeu3fX__-Ayudje3SmLjEFFHmLSnegzKujyYezuSh2yes6yqxhxM1HnjnNz0TApg==" rel="nofollow" target="_blank">CAMP4 Therapeutics Corporation</a> (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on July 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option to purchase 8,000 shares of the Company’s common stock to a newly hired employee of the Company as an inducement material to such http://www.streetinsider.com/Globe+Newswire/CAMP4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26784323.html Fri, 17 Jul 2026 16:05:00 -0400 CAMP http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Management+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html <p>X4 Pharmaceuticals (Nasdaq: XFOR) announced the appointment of Kelly Gold to its board of directors, effective July 1, 2026. Gold will serve as an independent director and member of the Audit Committee, according to a press release from the company.</p> <p>Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics (Nasdaq: CAMP), where she oversees corporate finance and accounting, investor relations, and strategic financial planning. Before becoming CFO at CAMP4, she held roles in business development and finance at the same company.</p> <p>Prior to CAMP4, Gold held corporate finance and business planning positions at Biogen, where she supported late-stage and marketed rare http://www.streetinsider.com/Board+Changes/X4+Pharmaceuticals+adds+Kelly+Gold+to+its+board+of+directors/26716681.html Wed, 01 Jul 2026 07:00:39 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html <p align="justify">BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=xyycIUDPprXngzptOUu8bLkYkwLYmunZ4HiJ9DfbWLnIKft_BDooM1Gje09DB2X7RbbUr4zUytNIzuoMxsOzpzbT_NxnUE4kyt5MOz8gzl8=" rel="nofollow" target="_blank"><strong>X4 Pharmaceuticals</strong></a> (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced the appointment of Kelly Gold to the Company’s Board of Directors effective July 1, 2026, adding strong strategic and financial expertise. Ms. Gold will serve as an independent director and member of the Audit Committee.</p> <p align="justify">“We are thrilled to welcome Kelly to our Board of Directors as she brings a distinct combination of financial leadership, capital markets expertise and a scientific background,” said Adam Craig, http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html Wed, 01 Jul 2026 07:00:00 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html <p align="justify">BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=xyycIUDPprXngzptOUu8bLkYkwLYmunZ4HiJ9DfbWLnIKft_BDooM1Gje09DB2X7RbbUr4zUytNIzuoMxsOzpzbT_NxnUE4kyt5MOz8gzl8=" rel="nofollow" target="_blank"><strong>X4 Pharmaceuticals</strong></a> (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced the appointment of Kelly Gold to the Company’s Board of Directors effective July 1, 2026, adding strong strategic and financial expertise. Ms. Gold will serve as an independent director and member of the Audit Committee.</p> <p align="justify">“We are thrilled to welcome Kelly to our Board of Directors as she brings a distinct combination of financial leadership, capital markets expertise and a scientific background,” said Adam Craig, http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html Wed, 01 Jul 2026 07:00:00 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html <p align="justify">BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=xyycIUDPprXngzptOUu8bLkYkwLYmunZ4HiJ9DfbWLnIKft_BDooM1Gje09DB2X7RbbUr4zUytNIzuoMxsOzpzbT_NxnUE4kyt5MOz8gzl8=" rel="nofollow" target="_blank"><strong>X4 Pharmaceuticals</strong></a> (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced the appointment of Kelly Gold to the Company’s Board of Directors effective July 1, 2026, adding strong strategic and financial expertise. Ms. Gold will serve as an independent director and member of the Audit Committee.</p> <p align="justify">“We are thrilled to welcome Kelly to our Board of Directors as she brings a distinct combination of financial leadership, capital markets expertise and a scientific background,” said Adam Craig, http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html Wed, 01 Jul 2026 07:00:00 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html <p align="justify">BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=xyycIUDPprXngzptOUu8bLkYkwLYmunZ4HiJ9DfbWLnIKft_BDooM1Gje09DB2X7RbbUr4zUytNIzuoMxsOzpzbT_NxnUE4kyt5MOz8gzl8=" rel="nofollow" target="_blank"><strong>X4 Pharmaceuticals</strong></a> (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced the appointment of Kelly Gold to the Company’s Board of Directors effective July 1, 2026, adding strong strategic and financial expertise. Ms. Gold will serve as an independent director and member of the Audit Committee.</p> <p align="justify">“We are thrilled to welcome Kelly to our Board of Directors as she brings a distinct combination of financial leadership, capital markets expertise and a scientific background,” said Adam Craig, http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html Wed, 01 Jul 2026 07:00:00 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html <p align="justify">BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=xyycIUDPprXngzptOUu8bLkYkwLYmunZ4HiJ9DfbWLnIKft_BDooM1Gje09DB2X7RbbUr4zUytNIzuoMxsOzpzbT_NxnUE4kyt5MOz8gzl8=" rel="nofollow" target="_blank"><strong>X4 Pharmaceuticals</strong></a> (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced the appointment of Kelly Gold to the Company’s Board of Directors effective July 1, 2026, adding strong strategic and financial expertise. Ms. Gold will serve as an independent director and member of the Audit Committee.</p> <p align="justify">“We are thrilled to welcome Kelly to our Board of Directors as she brings a distinct combination of financial leadership, capital markets expertise and a scientific background,” said Adam Craig, http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html Wed, 01 Jul 2026 07:00:00 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html <p align="justify">BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=xyycIUDPprXngzptOUu8bLkYkwLYmunZ4HiJ9DfbWLnIKft_BDooM1Gje09DB2X7RbbUr4zUytNIzuoMxsOzpzbT_NxnUE4kyt5MOz8gzl8=" rel="nofollow" target="_blank"><strong>X4 Pharmaceuticals</strong></a> (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced the appointment of Kelly Gold to the Company’s Board of Directors effective July 1, 2026, adding strong strategic and financial expertise. Ms. Gold will serve as an independent director and member of the Audit Committee.</p> <p align="justify">“We are thrilled to welcome Kelly to our Board of Directors as she brings a distinct combination of financial leadership, capital markets expertise and a scientific background,” said Adam Craig, http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html Wed, 01 Jul 2026 07:00:00 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html <p align="justify">BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=xyycIUDPprXngzptOUu8bLkYkwLYmunZ4HiJ9DfbWLnIKft_BDooM1Gje09DB2X7RbbUr4zUytNIzuoMxsOzpzbT_NxnUE4kyt5MOz8gzl8=" rel="nofollow" target="_blank"><strong>X4 Pharmaceuticals</strong></a> (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced the appointment of Kelly Gold to the Company’s Board of Directors effective July 1, 2026, adding strong strategic and financial expertise. Ms. Gold will serve as an independent director and member of the Audit Committee.</p> <p align="justify">“We are thrilled to welcome Kelly to our Board of Directors as she brings a distinct combination of financial leadership, capital markets expertise and a scientific background,” said Adam Craig, http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html Wed, 01 Jul 2026 07:00:00 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html <p align="justify">BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=xyycIUDPprXngzptOUu8bLkYkwLYmunZ4HiJ9DfbWLnIKft_BDooM1Gje09DB2X7RbbUr4zUytNIzuoMxsOzpzbT_NxnUE4kyt5MOz8gzl8=" rel="nofollow" target="_blank"><strong>X4 Pharmaceuticals</strong></a> (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced the appointment of Kelly Gold to the Company’s Board of Directors effective July 1, 2026, adding strong strategic and financial expertise. Ms. Gold will serve as an independent director and member of the Audit Committee.</p> <p align="justify">“We are thrilled to welcome Kelly to our Board of Directors as she brings a distinct combination of financial leadership, capital markets expertise and a scientific background,” said Adam Craig, http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html Wed, 01 Jul 2026 07:00:00 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html <p align="justify">BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=xyycIUDPprXngzptOUu8bLkYkwLYmunZ4HiJ9DfbWLnIKft_BDooM1Gje09DB2X7RbbUr4zUytNIzuoMxsOzpzbT_NxnUE4kyt5MOz8gzl8=" rel="nofollow" target="_blank"><strong>X4 Pharmaceuticals</strong></a> (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced the appointment of Kelly Gold to the Company’s Board of Directors effective July 1, 2026, adding strong strategic and financial expertise. Ms. Gold will serve as an independent director and member of the Audit Committee.</p> <p align="justify">“We are thrilled to welcome Kelly to our Board of Directors as she brings a distinct combination of financial leadership, capital markets expertise and a scientific background,” said Adam Craig, http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+Appoints+Kelly+Gold%2C+Experienced+Chief+Financial+Officer%2C+to+its+Board+of+Directors/26716641.html Wed, 01 Jul 2026 07:00:00 -0400 A.50216632 A.60012009 CAMP O.34387572 O.36917942 O.38234333 XFOR